Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology

NCT02847130 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 530

Last updated 2023-07-19

No results posted yet for this study

Summary

This research trial studies the use of clinical practice guidelines by pediatric oncology healthcare providers in order to identify, understand, and overcome barriers to them. The treatments for childhood cancers are intense and result in a high rate of symptoms which require support by healthcare providers. By reviewing patients' medical chart records, meeting in focus groups and in one-on-one interviews, healthcare providers may improve how clinical practice guidelines are used to support children undergoing cancer treatment.

Conditions

  • Acute Lymphoblastic Leukemia
  • B-Cell Non-Hodgkin Lymphoma
  • Childhood Acute Myeloid Leukemia
  • Childhood Burkitt Lymphoma
  • Childhood Neoplasm
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Recurrent Childhood Acute Lymphoblastic Leukemia

Interventions

OTHER

Informational Intervention

Participate in focus group

OTHER

Interview

Undergo one-on-one interviews

OTHER

Medical Chart Review

Review of medical chart

OTHER

Questionnaire Administration

Ancillary studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • L. Lee Dupuis · Children's Oncology Group

Eligibility

Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-21
Primary Completion
2023-03-31
Completion
2023-06-30

Countries

  • United States
  • Puerto Rico

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02847130 on ClinicalTrials.gov